Jim Cramer highlighted Amgen for its strong fundamentals amid market fluctuations.
Amgen Inc has caught the attention of Jim Cramer, who noted the company's solid financial performance. The stock closed at US$411.03, down 1.37% on the day. Over the past week, it increased by 0.04%, and it rose by 3.63% over the last month. Year-to-date, Amgen has gained 26.90%.
Advertisement
Amgen Inc
AMGN.US
AMGN.US
Amgen Inc
WealthAwesomeMarket cap
$223.32B
P/E
25.0x
Div. yield
2.43%
Div. / share
$9.80
52W high
$447.03
52W low
$280.23
1W change
+0.04%
Beta
0.41
Analyst Price Targets
Based on 34 analysts covering AMGN · as of Oct 9, 2026
Wall Street analysts forecast AMGN stock price to fall 3.9% over the next 12 months.
Consensus
Hold3.35 / 5.00
Avg. Target
C$391.46
-3.9% Upside
Previously C$390.94 on Oct 5, 2026
Current Price
C$407.44
Last close
Analyst Breakdown (34 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AMGN's historical volatility
30-Day Vol
40.1%
Annualized
90-Day Vol
32.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$487.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$432.43 | C$376.50 – C$496.67 |
| 60 trading days | C$458.95 | C$377.31 – C$558.25 |
| 90 trading days | C$487.10 | C$383.21 – C$619.16 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Amgen's performance and Cramer's endorsement may influence investor sentiment but should be evaluated in the context of broader market conditions.
Amgen’s Stock Closes at US$411.03, Down 1.37%
Advertisement
With a trading volume of 403,725 shares, Amgen's activity was below its 20-day average of 3,126,506 shares.
Bull case
Cramer’s focus on Amgen could boost investor confidence, especially given the company's strong profit margins and return on equity. Amgen's profit margin stands at 22.9%, and its return on equity is an impressive 91.5%. The earnings per share (EPS) is 16.52, indicating solid profitability. Investors seem willing to pay a premium for its earnings, as reflected in the price-to-earnings (P/E) ratio of 25.00, which suggests confidence in its future growth prospects.
Bear case
Despite Cramer’s attention, Amgen's stock is currently trading below the average analyst target, indicating potential challenges ahead. The stock has a 52-week range of US$280.23 to US$447.03, currently sitting at 78% of that range. Investors will be watching how the stock performs in the coming days, especially with upcoming financial disclosures, as the company navigates the healthcare market landscape.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
